Recruiting Bronchiectasis Studies in Denver
The AIRTIVITY® Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
This study is open to adults with bronchiectasis. People can participate in this study if they produce sputum and have had flare-ups (also called exacerbations). The purpose of this study is to find ...
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
This study is a randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of ensifentrine inhalation suspension (3 mg) delivered twice daily via standard jet nebuli...
About Bronchiectasis Clinical Trials in Denver
Bronchiectasis is a chronic condition where the bronchial tubes of the lungs are permanently widened, leading to a buildup of mucus and repeated infections. It can result from various causes including infections and genetic conditions. Treatment includes airway clearance, antibiotics, and anti-inflammatory medications.
There are currently 2 bronchiectasis clinical trials recruiting participants in Denver, CO. These studies are seeking a combined 1,860 participants. Research is being sponsored by Boehringer Ingelheim, Verona Pharma plc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Bronchiectasis Clinical Trials in Denver — FAQ
Are there bronchiectasis clinical trials in Denver?
Yes, there are 2 bronchiectasis clinical trials currently recruiting in Denver, CO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Denver?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you about next steps.
Are clinical trials in Denver free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Denver studies also compensate for your time and travel.
What bronchiectasis treatments are being tested?
The 2 active trials in Denver are testing new therapies including novel drugs, biologics, and treatment approaches for bronchiectasis.
Data updated March 2, 2026 from ClinicalTrials.gov